The AllCells Blog

AllCells Blog

AllCells blog posts are dedicated to highlighting scientific trends, innovation, and technological advances within the biomedical industry. Data-driven studies and primary research are conducted to create our blogs and include experts within the following fields: immuno-oncologists, cell and gene therapy, academia, government, and contract research organizations.

A Decade of Innovation: CAR-T Successes and Latest Developments

July 6, 2022

After a decade of innovation, chimeric antigen receptor (CAR)-T cell therapy remains at the forefront of the cell and gene therapy space, continuing to forge new ground to treat previously […]

Cell Therapy

Why You Should Start Clinical Grade Cell Supply Discussions Early in Cell and Gene Therapy Development

May 24, 2022

Cell and gene therapies represent an expanding category of transformative medicines with the potential to change the way we treat human diseases. Broadly, these novel therapies include both in vivo […]

Dna Double Helix

What You Need to Know About Regenerative Medicine in 2022: Industry and Tech Trends

April 20, 2022

Growth in the Regenerative Medicine Field The regenerative medicine sector is on track for another watershed year where clinical progress, continued growth, and segmentation into new disease areas affecting larger […]

AllCells Opens a New Collection Facility in Houston, Texas

March 29, 2022

Expanding Its Donor Network AllCells, the leading provider of human hematological products and services, is pleased to announce the opening of a new, 3600 sq ft LeukoLab cell collection facility […]

Donor Management Services

A Donor-Centric Approach to Cell and Gene Therapy

February 3, 2022

In the past decade, emerging therapeutic modalities like cell and gene therapies have opened up new treatment options for previously intractable diseases, changing the industry needs for primary tissues. While […]


AllCells Announces First to Market Launch of In Stock GMP-Compliant Cryopreserved Leukopaks

January 28, 2022

Collected from qualified healthy donors that meet baseline FDA 21 CFR 1271 requirements, industry’s first In Stock GMP-compliant Cryopreserved Leukopaks significantly decrease lead time AllCells, the industry leader in the […]

AllCells cryopreserved cells in vial

FAQ Series: The Science Behind Cryopreservation

January 11, 2022

Primary cells, such as those isolated from the bone marrow or peripheral blood, are important for a wide scope of research and clinical applications – from studying molecular mechanisms driving disease progression, to […]

AllCells GMP compliant Leukopak cells

GMP-Compliant Leukopaks for Allogeneic Cell Therapies

December 13, 2021

Adoptive cell therapies (ACTs), which is a treatment based on transferring cells (most often immune cells) into a patient, have revolutionized the standard of care to treat a broad range […]

AllCells GMP cryopreserved leukopak

GMP-Compliant Leukopaks Mitigate Risk in Cell and Gene Therapy Workflows

December 13, 2021

Isolated human primary cells are able to retain the morphological and functional characteristics of their tissue of origin, which makes them invaluable tools in life sciences to advance our understanding […]

AllCells' Cleanroom

AllCells Announces New GMP Cleanroom

December 13, 2021

Expansion of GMP capabilities to support the rapidly growing cell and gene therapy industry AllCells Alameda, CA Expands GMP Processing Capabilities AllCells, the industry leader in the procurement and customization […]

Subscribe to Our Blog

Stay current with the AllCells Blog. Get email updates with helpful resources for biomedical researchers:

Customer Service

How Can We Help You?

Looking for research tips? Need help sourcing materials? How about a few more articles on therapies or processes? At AllCells, we believe that partnerships create the best pathways to success. Our Customer Success Team has years of industry experience and a wealth of resources to help you get the most out of your cellular products. We’re only a few clicks away.

Contact Us
Have a question? Let’s chat.